Christopher P. Rusconi

4.0k total citations · 1 hit paper
37 papers, 2.9k citations indexed

About

Christopher P. Rusconi is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Christopher P. Rusconi has authored 37 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 16 papers in Cardiology and Cardiovascular Medicine and 15 papers in Molecular Biology. Recurrent topics in Christopher P. Rusconi's work include Blood Coagulation and Thrombosis Mechanisms (18 papers), Atrial Fibrillation Management and Outcomes (11 papers) and Advanced biosensing and bioanalysis techniques (8 papers). Christopher P. Rusconi is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (18 papers), Atrial Fibrillation Management and Outcomes (11 papers) and Advanced biosensing and bioanalysis techniques (8 papers). Christopher P. Rusconi collaborates with scholars based in United States, Germany and Canada. Christopher P. Rusconi's co-authors include Bruce A. Sullenger, Shahid M. Nimjee, Rebekah R. White, George A. Pitoc, Juliana M. Layzer, Dougald M. Monroe, Thomas L. Ortel, Richard C. Becker, John H. Alexander and Thomas R. Cech and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Christopher P. Rusconi

36 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Aptamers: An Emerging Class of Therapeutics

2005 747 citations Shahid M. Nimjee, Christopher P. Rusconi et al. profile →

Peers

Christopher P. Rusconi

HEMAT

CCM

RNMI

Juliana M. Layzer United States

Raymond T. Camphausen United States

Colin F. Greineder United States

Christian Schwöppe Germany

Suet‐Mien Tan Singapore

Staffan Sandgren Sweden

Steven M. Ansell United States

Małgorzata Wilczyńska Sweden

Serena Mazzucchelli Italy

G. E. Francis United Kingdom

Juliana M. Layzer United States

Christopher P. Rusconi

1.2k ×0.5

162 ×0.3

179 ×0.4

HEMAT

66 ×0.2

CCM

69 ×0.4

RNMI

Citations per year, relative to Christopher P. Rusconi Christopher P. Rusconi (= 1×) peers Juliana M. Layzer

Countries citing papers authored by Christopher P. Rusconi

Since Specialization

Citations

This map shows the geographic impact of Christopher P. Rusconi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher P. Rusconi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher P. Rusconi more than expected).

Fields of papers citing papers by Christopher P. Rusconi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher P. Rusconi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher P. Rusconi. The network helps show where Christopher P. Rusconi may publish in the future.

Co-authorship network of co-authors of Christopher P. Rusconi

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher P. Rusconi. A scholar is included among the top collaborators of Christopher P. Rusconi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher P. Rusconi. Christopher P. Rusconi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vavalle, John P., Christopher P. Rusconi, Steven L. Zelenkofske, et al.. (2014). The effect of the REG2 Anticoagulation System on thrombin generation kinetics: a pharmacodynamic and pharmacokinetic first-in-human study. Journal of Thrombosis and Thrombolysis. 38(3). 275–284. 8 indexed citations

Povsic, Thomas J., Mauricio G. Cohen, Roxana Mehran, et al.. (2011). A randomized, partially blinded, multicenter, active-controlled, dose-ranging study assessing the safety, efficacy, and pharmacodynamics of the REG1 anticoagulation system in patients with acute coronary syndromes: Design and rationale of the RADAR Phase IIb trial. American Heart Journal. 161(2). 261–268.e2. 26 indexed citations

Povsic, Thomas J., William A. Wargin, John H. Alexander, et al.. (2011). Pegnivacogin results in near complete FIX inhibition in acute coronary syndrome patients: RADAR pharmacokinetic and pharmacodynamic substudy. European Heart Journal. 32(19). 2412–2419. 32 indexed citations

Chan, Mark Y., et al.. (2011). Factor IXa as a Target for Pharmacologic Inhibition in Acute Coronary Syndrome. Cardiovascular Therapeutics. 29(4). e22–e35. 6 indexed citations

Rusconi, Christopher P., et al.. (2010). Abstract 10787: Discovery of a Novel Aptamer-based Inhibitor of GPVI and its Matched Active Control Agent. Circulation. 122. 1 indexed citations

Povsic, Thomas J., William A. Wargin, Mauricio G. Cohen, et al.. (2010). Abstract 13255: RB006, a Direct Factor IX Inhibitor Results in Consistent and Near Complete Inhibition of Factor IX in Patients with Acute Coronary Syndromes: A RADAR Pharmacokinetic and Pharmacodynamic Substudy. Circulation. 122. 1 indexed citations

Cohen, Mauricio G., Drew A. Purdy, Joseph S. Rossi, et al.. (2010). FACTOR IXA INHIBITION WITH REG1 PROVIDES RAPID ONSET, STABLE AND ACTIVELY CONTROLLED ANTICOAGULATION DURING PCI. Journal of the American College of Cardiology. 55(10). A206.E1940–A206.E1940. 1 indexed citations

Rusconi, Christopher P., Doug Kornbrust, & Steven L. Zelenkofske. (2010). SUBCUTANEOUS FIXA INHIBITOR PROVIDES PROLONGED ANTICOAGULATION: THE FIRST SUCCESSFUL SUBCUTANEOUS APPLICATION OF AN APTAMER. Journal of the American College of Cardiology. 55(10). A172.E1618–A172.E1618. 3 indexed citations

Povsic, Thomas J., Bruce A. Sullenger, Steven L. Zelenkofske, Christopher P. Rusconi, & Richard C. Becker. (2010). Translating Nucleic Acid Aptamers to Antithrombotic Drugs in Cardiovascular Medicine. Journal of Cardiovascular Translational Research. 3(6). 704–716. 12 indexed citations

10.

Layzer, Juliana M., Genmin Lu, Christopher P. Rusconi, et al.. (2009). An Anticoagulant RNA Aptamer That Inhibits Proteinase-Cofactor Interactions within Prothrombinase. Journal of Biological Chemistry. 285(8). 5212–5223. 37 indexed citations

11.

Kleiman, Neal S., Jane E. Freedman, Paula B. Tracy, et al.. (2008). Platelets: Developmental biology, physiology, and translatable platforms for preclinical investigation and drug development. Platelets. 19(4). 239–251. 14 indexed citations

12.

Howard, Emily L., Kristian C. Becker, Christopher P. Rusconi, & Richard C. Becker. (2007). Factor IXa Inhibitors as Novel Anticoagulants. Arteriosclerosis Thrombosis and Vascular Biology. 27(4). 722–727. 69 indexed citations

13.

Dyke, Christopher K., Steven R. Steinhubl, Neal S. Kleiman, et al.. (2006). First-in-Human Experience of an Antidote-Controlled Anticoagulant Using RNA Aptamer Technology. Circulation. 114(23). 2490–2497. 166 indexed citations

14.

Nimjee, Shahid M., Janelle R. Keys, George A. Pitoc, et al.. (2006). A Novel Antidote-Controlled Anticoagulant Reduces Thrombin Generation and Inflammation and Improves Cardiac Function in Cardiopulmonary Bypass Surgery. Molecular Therapy. 14(3). 408–415. 69 indexed citations

15.

Rusconi, Christopher P., J. Devin Roberts, George A. Pitoc, et al.. (2004). Antidote-mediated control of an anticoagulant aptamer in vivo. Nature Biotechnology. 22(11). 1423–1428. 273 indexed citations

16.

Potti, Anil, Christopher P. Rusconi, Bruce A. Sullenger, & Thomas L. Ortel. (2004). Regulatable aptamers in medicine: focus on antithrombotic strategies. Expert Opinion on Biological Therapy. 4(10). 1641–1647. 5 indexed citations

17.

Sullenger, Bruce A., Rebekah R. White, & Christopher P. Rusconi. (2003). Therapeutic Aptamers and Antidotes: A Novel Approach to Safer Drug Design. PubMed. 217–223. 4 indexed citations

18.

White, Rebekah R., Bruce A. Sullenger, & Christopher P. Rusconi. (2000). Developing aptamers into therapeutics. Journal of Clinical Investigation. 106(8). 929–934. 237 indexed citations

19.

Faust, J R, et al.. (1998). Identification and sequencing of two isopentenyladenosine-modified transfer RNAs from Chinese hamster ovary cells. Nucleic Acids Research. 26(23). 5533–5535. 5 indexed citations

20.

Rusconi, Christopher P. & Thomas R. Cech. (1996). The anticodon is the signal sequence for mitochondrial import of glutamine tRNA in Tetrahymena.. Genes & Development. 10(22). 2870–2880. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact